Global CAR T-Cell Therapy Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 138
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global CAR T-Cell Therapy Agents market size was valued at USD 376.6 million in 2023 and is forecast to a readjusted size of USD 592.9 million by 2030 with a CAGR of 6.7% during review period.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the CAR T-Cell Therapy Agents industry chain, the market status of Lymphoma (CD19-targeted, BCMA-targeted), Multiple Myeloma (CD19-targeted, BCMA-targeted), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CAR T-Cell Therapy Agents.
Regionally, the report analyzes the CAR T-Cell Therapy Agents markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CAR T-Cell Therapy Agents market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CAR T-Cell Therapy Agents market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CAR T-Cell Therapy Agents industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CD19-targeted, BCMA-targeted).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CAR T-Cell Therapy Agents market.
Regional Analysis: The report involves examining the CAR T-Cell Therapy Agents market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CAR T-Cell Therapy Agents market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CAR T-Cell Therapy Agents:
Company Analysis: Report covers individual CAR T-Cell Therapy Agents players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CAR T-Cell Therapy Agents This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Lymphoma, Multiple Myeloma).
Technology Analysis: Report covers specific technologies relevant to CAR T-Cell Therapy Agents. It assesses the current state, advancements, and potential future developments in CAR T-Cell Therapy Agents areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CAR T-Cell Therapy Agents market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CAR T-Cell Therapy Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
CD19-targeted
BCMA-targeted
Market segment by Application
Lymphoma
Multiple Myeloma
Market segment by players, this report covers
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR T-Cell Therapy Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-Cell Therapy Agents, with revenue, gross margin and global market share of CAR T-Cell Therapy Agents from 2019 to 2024.
Chapter 3, the CAR T-Cell Therapy Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CAR T-Cell Therapy Agents market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-Cell Therapy Agents.
Chapter 13, to describe CAR T-Cell Therapy Agents research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of CAR T-Cell Therapy Agents
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CAR T-Cell Therapy Agents by Type
1.3.1 Overview: Global CAR T-Cell Therapy Agents Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global CAR T-Cell Therapy Agents Consumption Value Market Share by Type in 2023
1.3.3 CD19-targeted
1.3.4 BCMA-targeted
1.4 Global CAR T-Cell Therapy Agents Market by Application
1.4.1 Overview: Global CAR T-Cell Therapy Agents Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Lymphoma
1.4.3 Multiple Myeloma
1.5 Global CAR T-Cell Therapy Agents Market Size & Forecast
1.6 Global CAR T-Cell Therapy Agents Market Size and Forecast by Region
1.6.1 Global CAR T-Cell Therapy Agents Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global CAR T-Cell Therapy Agents Market Size by Region, (2019-2030)
1.6.3 North America CAR T-Cell Therapy Agents Market Size and Prospect (2019-2030)
1.6.4 Europe CAR T-Cell Therapy Agents Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific CAR T-Cell Therapy Agents Market Size and Prospect (2019-2030)
1.6.6 South America CAR T-Cell Therapy Agents Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa CAR T-Cell Therapy Agents Market Size and Prospect (2019-2030)
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis CAR T-Cell Therapy Agents Product and Solutions
2.1.4 Novartis CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR T-Cell Therapy Agents Product and Solutions
2.2.4 Gilead Sciences CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product and Solutions
2.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 J & J
2.4.1 J & J Details
2.4.2 J & J Major Business
2.4.3 J & J CAR T-Cell Therapy Agents Product and Solutions
2.4.4 J & J CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 J & J Recent Developments and Future Plans
2.5 JW Therapeutics
2.5.1 JW Therapeutics Details
2.5.2 JW Therapeutics Major Business
2.5.3 JW Therapeutics CAR T-Cell Therapy Agents Product and Solutions
2.5.4 JW Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 JW Therapeutics Recent Developments and Future Plans
2.6 FOSUNKite
2.6.1 FOSUNKite Details
2.6.2 FOSUNKite Major Business
2.6.3 FOSUNKite CAR T-Cell Therapy Agents Product and Solutions
2.6.4 FOSUNKite CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 FOSUNKite Recent Developments and Future Plans
2.7 CARsgen Therapeutics (Pipeline)
2.7.1 CARsgen Therapeutics (Pipeline) Details
2.7.2 CARsgen Therapeutics (Pipeline) Major Business
2.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product and Solutions
2.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
2.8 CARsgen Therapeutics
2.8.1 CARsgen Therapeutics Details
2.8.2 CARsgen Therapeutics Major Business
2.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Product and Solutions
2.8.4 CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 CARsgen Therapeutics Recent Developments and Future Plans
2.9 Autolus Therapeutics
2.9.1 Autolus Therapeutics Details
2.9.2 Autolus Therapeutics Major Business
2.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Product and Solutions
2.9.4 Autolus Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Autolus Therapeutics Recent Developments and Future Plans
2.10 Sorrento Therapeutics
2.10.1 Sorrento Therapeutics Details
2.10.2 Sorrento Therapeutics Major Business
2.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Product and Solutions
2.10.4 Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sorrento Therapeutics Recent Developments and Future Plans
2.11 Mustang Bio
2.11.1 Mustang Bio Details
2.11.2 Mustang Bio Major Business
2.11.3 Mustang Bio CAR T-Cell Therapy Agents Product and Solutions
2.11.4 Mustang Bio CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Mustang Bio Recent Developments and Future Plans
2.12 Bluebird Bio
2.12.1 Bluebird Bio Details
2.12.2 Bluebird Bio Major Business
2.12.3 Bluebird Bio CAR T-Cell Therapy Agents Product and Solutions
2.12.4 Bluebird Bio CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bluebird Bio Recent Developments and Future Plans
2.13 Cellectis
2.13.1 Cellectis Details
2.13.2 Cellectis Major Business
2.13.3 Cellectis CAR T-Cell Therapy Agents Product and Solutions
2.13.4 Cellectis CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cellectis Recent Developments and Future Plans
2.14 Allogene Therapeutics
2.14.1 Allogene Therapeutics Details
2.14.2 Allogene Therapeutics Major Business
2.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Product and Solutions
2.14.4 Allogene Therapeutics CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Allogene Therapeutics Recent Developments and Future Plans
2.15 Celyad
2.15.1 Celyad Details
2.15.2 Celyad Major Business
2.15.3 Celyad CAR T-Cell Therapy Agents Product and Solutions
2.15.4 Celyad CAR T-Cell Therapy Agents Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Celyad Recent Developments and Future Plans
3.1 Global CAR T-Cell Therapy Agents Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of CAR T-Cell Therapy Agents by Company Revenue
3.2.2 Top 3 CAR T-Cell Therapy Agents Players Market Share in 2023
3.2.3 Top 6 CAR T-Cell Therapy Agents Players Market Share in 2023
3.3 CAR T-Cell Therapy Agents Market: Overall Company Footprint Analysis
3.3.1 CAR T-Cell Therapy Agents Market: Region Footprint
3.3.2 CAR T-Cell Therapy Agents Market: Company Product Type Footprint
3.3.3 CAR T-Cell Therapy Agents Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global CAR T-Cell Therapy Agents Consumption Value and Market Share by Type (2019-2024)
4.2 Global CAR T-Cell Therapy Agents Market Forecast by Type (2025-2030)
5.1 Global CAR T-Cell Therapy Agents Consumption Value Market Share by Application (2019-2024)
5.2 Global CAR T-Cell Therapy Agents Market Forecast by Application (2025-2030)
6.1 North America CAR T-Cell Therapy Agents Consumption Value by Type (2019-2030)
6.2 North America CAR T-Cell Therapy Agents Consumption Value by Application (2019-2030)
6.3 North America CAR T-Cell Therapy Agents Market Size by Country
6.3.1 North America CAR T-Cell Therapy Agents Consumption Value by Country (2019-2030)
6.3.2 United States CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
6.3.3 Canada CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
6.3.4 Mexico CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
7.1 Europe CAR T-Cell Therapy Agents Consumption Value by Type (2019-2030)
7.2 Europe CAR T-Cell Therapy Agents Consumption Value by Application (2019-2030)
7.3 Europe CAR T-Cell Therapy Agents Market Size by Country
7.3.1 Europe CAR T-Cell Therapy Agents Consumption Value by Country (2019-2030)
7.3.2 Germany CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
7.3.3 France CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
7.3.4 United Kingdom CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
7.3.5 Russia CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
7.3.6 Italy CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
8.1 Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region
8.3.1 Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Region (2019-2030)
8.3.2 China CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
8.3.3 Japan CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
8.3.4 South Korea CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
8.3.5 India CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
8.3.7 Australia CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
9.1 South America CAR T-Cell Therapy Agents Consumption Value by Type (2019-2030)
9.2 South America CAR T-Cell Therapy Agents Consumption Value by Application (2019-2030)
9.3 South America CAR T-Cell Therapy Agents Market Size by Country
9.3.1 South America CAR T-Cell Therapy Agents Consumption Value by Country (2019-2030)
9.3.2 Brazil CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
9.3.3 Argentina CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
10.1 Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country
10.3.1 Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Country (2019-2030)
10.3.2 Turkey CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
10.3.4 UAE CAR T-Cell Therapy Agents Market Size and Forecast (2019-2030)
11.1 CAR T-Cell Therapy Agents Market Drivers
11.2 CAR T-Cell Therapy Agents Market Restraints
11.3 CAR T-Cell Therapy Agents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 CAR T-Cell Therapy Agents Industry Chain
12.2 CAR T-Cell Therapy Agents Upstream Analysis
12.3 CAR T-Cell Therapy Agents Midstream Analysis
12.4 CAR T-Cell Therapy Agents Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global CAR T-Cell Therapy Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global CAR T-Cell Therapy Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global CAR T-Cell Therapy Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global CAR T-Cell Therapy Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis CAR T-Cell Therapy Agents Product and Solutions
Table 8. Novartis CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences CAR T-Cell Therapy Agents Product and Solutions
Table 13. Gilead Sciences CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Gilead Sciences Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product and Solutions
Table 18. Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
Table 20. J & J Company Information, Head Office, and Major Competitors
Table 21. J & J Major Business
Table 22. J & J CAR T-Cell Therapy Agents Product and Solutions
Table 23. J & J CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. J & J Recent Developments and Future Plans
Table 25. JW Therapeutics Company Information, Head Office, and Major Competitors
Table 26. JW Therapeutics Major Business
Table 27. JW Therapeutics CAR T-Cell Therapy Agents Product and Solutions
Table 28. JW Therapeutics CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. JW Therapeutics Recent Developments and Future Plans
Table 30. FOSUNKite Company Information, Head Office, and Major Competitors
Table 31. FOSUNKite Major Business
Table 32. FOSUNKite CAR T-Cell Therapy Agents Product and Solutions
Table 33. FOSUNKite CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. FOSUNKite Recent Developments and Future Plans
Table 35. CARsgen Therapeutics (Pipeline) Company Information, Head Office, and Major Competitors
Table 36. CARsgen Therapeutics (Pipeline) Major Business
Table 37. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product and Solutions
Table 38. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
Table 40. CARsgen Therapeutics Company Information, Head Office, and Major Competitors
Table 41. CARsgen Therapeutics Major Business
Table 42. CARsgen Therapeutics CAR T-Cell Therapy Agents Product and Solutions
Table 43. CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. CARsgen Therapeutics Recent Developments and Future Plans
Table 45. Autolus Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Autolus Therapeutics Major Business
Table 47. Autolus Therapeutics CAR T-Cell Therapy Agents Product and Solutions
Table 48. Autolus Therapeutics CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Autolus Therapeutics Recent Developments and Future Plans
Table 50. Sorrento Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Sorrento Therapeutics Major Business
Table 52. Sorrento Therapeutics CAR T-Cell Therapy Agents Product and Solutions
Table 53. Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sorrento Therapeutics Recent Developments and Future Plans
Table 55. Mustang Bio Company Information, Head Office, and Major Competitors
Table 56. Mustang Bio Major Business
Table 57. Mustang Bio CAR T-Cell Therapy Agents Product and Solutions
Table 58. Mustang Bio CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Mustang Bio Recent Developments and Future Plans
Table 60. Bluebird Bio Company Information, Head Office, and Major Competitors
Table 61. Bluebird Bio Major Business
Table 62. Bluebird Bio CAR T-Cell Therapy Agents Product and Solutions
Table 63. Bluebird Bio CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Bluebird Bio Recent Developments and Future Plans
Table 65. Cellectis Company Information, Head Office, and Major Competitors
Table 66. Cellectis Major Business
Table 67. Cellectis CAR T-Cell Therapy Agents Product and Solutions
Table 68. Cellectis CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Cellectis Recent Developments and Future Plans
Table 70. Allogene Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Allogene Therapeutics Major Business
Table 72. Allogene Therapeutics CAR T-Cell Therapy Agents Product and Solutions
Table 73. Allogene Therapeutics CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Allogene Therapeutics Recent Developments and Future Plans
Table 75. Celyad Company Information, Head Office, and Major Competitors
Table 76. Celyad Major Business
Table 77. Celyad CAR T-Cell Therapy Agents Product and Solutions
Table 78. Celyad CAR T-Cell Therapy Agents Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Celyad Recent Developments and Future Plans
Table 80. Global CAR T-Cell Therapy Agents Revenue (USD Million) by Players (2019-2024)
Table 81. Global CAR T-Cell Therapy Agents Revenue Share by Players (2019-2024)
Table 82. Breakdown of CAR T-Cell Therapy Agents by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in CAR T-Cell Therapy Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key CAR T-Cell Therapy Agents Players
Table 85. CAR T-Cell Therapy Agents Market: Company Product Type Footprint
Table 86. CAR T-Cell Therapy Agents Market: Company Product Application Footprint
Table 87. CAR T-Cell Therapy Agents New Market Entrants and Barriers to Market Entry
Table 88. CAR T-Cell Therapy Agents Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global CAR T-Cell Therapy Agents Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global CAR T-Cell Therapy Agents Consumption Value Share by Type (2019-2024)
Table 91. Global CAR T-Cell Therapy Agents Consumption Value Forecast by Type (2025-2030)
Table 92. Global CAR T-Cell Therapy Agents Consumption Value by Application (2019-2024)
Table 93. Global CAR T-Cell Therapy Agents Consumption Value Forecast by Application (2025-2030)
Table 94. North America CAR T-Cell Therapy Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America CAR T-Cell Therapy Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America CAR T-Cell Therapy Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America CAR T-Cell Therapy Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America CAR T-Cell Therapy Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America CAR T-Cell Therapy Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe CAR T-Cell Therapy Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe CAR T-Cell Therapy Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe CAR T-Cell Therapy Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe CAR T-Cell Therapy Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe CAR T-Cell Therapy Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe CAR T-Cell Therapy Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America CAR T-Cell Therapy Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America CAR T-Cell Therapy Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America CAR T-Cell Therapy Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America CAR T-Cell Therapy Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America CAR T-Cell Therapy Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America CAR T-Cell Therapy Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa CAR T-Cell Therapy Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 124. CAR T-Cell Therapy Agents Raw Material
Table 125. Key Suppliers of CAR T-Cell Therapy Agents Raw Materials
List of Figures
Figure 1. CAR T-Cell Therapy Agents Picture
Figure 2. Global CAR T-Cell Therapy Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global CAR T-Cell Therapy Agents Consumption Value Market Share by Type in 2023
Figure 4. CD19-targeted
Figure 5. BCMA-targeted
Figure 6. Global CAR T-Cell Therapy Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. CAR T-Cell Therapy Agents Consumption Value Market Share by Application in 2023
Figure 8. Lymphoma Picture
Figure 9. Multiple Myeloma Picture
Figure 10. Global CAR T-Cell Therapy Agents Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global CAR T-Cell Therapy Agents Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market CAR T-Cell Therapy Agents Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global CAR T-Cell Therapy Agents Consumption Value Market Share by Region (2019-2030)
Figure 14. Global CAR T-Cell Therapy Agents Consumption Value Market Share by Region in 2023
Figure 15. North America CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 18. South America CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 20. Global CAR T-Cell Therapy Agents Revenue Share by Players in 2023
Figure 21. CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players CAR T-Cell Therapy Agents Market Share in 2023
Figure 23. Global Top 6 Players CAR T-Cell Therapy Agents Market Share in 2023
Figure 24. Global CAR T-Cell Therapy Agents Consumption Value Share by Type (2019-2024)
Figure 25. Global CAR T-Cell Therapy Agents Market Share Forecast by Type (2025-2030)
Figure 26. Global CAR T-Cell Therapy Agents Consumption Value Share by Application (2019-2024)
Figure 27. Global CAR T-Cell Therapy Agents Market Share Forecast by Application (2025-2030)
Figure 28. North America CAR T-Cell Therapy Agents Consumption Value Market Share by Type (2019-2030)
Figure 29. North America CAR T-Cell Therapy Agents Consumption Value Market Share by Application (2019-2030)
Figure 30. North America CAR T-Cell Therapy Agents Consumption Value Market Share by Country (2019-2030)
Figure 31. United States CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe CAR T-Cell Therapy Agents Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe CAR T-Cell Therapy Agents Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe CAR T-Cell Therapy Agents Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 38. France CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific CAR T-Cell Therapy Agents Consumption Value Market Share by Region (2019-2030)
Figure 45. China CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 48. India CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 51. South America CAR T-Cell Therapy Agents Consumption Value Market Share by Type (2019-2030)
Figure 52. South America CAR T-Cell Therapy Agents Consumption Value Market Share by Application (2019-2030)
Figure 53. South America CAR T-Cell Therapy Agents Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa CAR T-Cell Therapy Agents Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa CAR T-Cell Therapy Agents Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa CAR T-Cell Therapy Agents Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE CAR T-Cell Therapy Agents Consumption Value (2019-2030) & (USD Million)
Figure 62. CAR T-Cell Therapy Agents Market Drivers
Figure 63. CAR T-Cell Therapy Agents Market Restraints
Figure 64. CAR T-Cell Therapy Agents Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of CAR T-Cell Therapy Agents in 2023
Figure 67. Manufacturing Process Analysis of CAR T-Cell Therapy Agents
Figure 68. CAR T-Cell Therapy Agents Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis Gilead Sciences Bristol-Myers Squibb J & J JW Therapeutics FOSUNKite CARsgen Therapeutics (Pipeline) CARsgen Therapeutics Autolus Therapeutics Sorrento Therapeutics Mustang Bio Bluebird Bio Cellectis Allogene Therapeutics Celyad
Related Reports
04 Sep 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
